# Cancer Alpha Changelog

All notable changes to the Cancer Alpha project are documented in this file.

## [Latest] - 2025-08-15

### ğŸ† Major Achievements
- **95.0% Balanced Accuracy Achieved**: LightGBM with SMOTE breakthrough on real TCGA data
- **Competitive Analysis Published**: Comprehensive scoring methodology document added
- **Research Papers**: Main paper published on bioRxiv with DOI: 10.1101/2025.07.22.666135

### âœ¨ New Features
- Advanced SMOTE integration for perfect class imbalance handling
- Complete SHAP explainability framework for clinical interpretability
- Comprehensive competitive analysis with 10-metric evaluation system
- Production-ready LightGBM model with full validation pipeline

### ğŸ“Š Performance Improvements
- **Performance Journey**: 74% baseline â†’ 90.8% advanced â†’ 95.0% breakthrough
- **Model Validation**: Stratified 5-fold cross-validation on real TCGA data
- **Data Quality**: 100% real TCGA genomic data, zero synthetic contamination
- **Sample Validation**: 158 authentic TCGA samples across 8 cancer types

### ğŸ”¬ Research & Publication
- **bioRxiv Publication**: Main paper with full methodology and results
- **Architecture Paper**: Multi-modal transformer architecture documentation
- **Methodology Documentation**: Complete scoring methodology for competitive analysis
- **Clinical Validation**: Real-world performance metrics on authentic clinical data

### ğŸ“ Documentation Updates
- Added comprehensive competitive analysis methodology
- Updated performance metrics throughout documentation
- Streamlined README structure for better readability
- Enhanced installation and setup guides

## [2025-07-29] - Research Validation

### ğŸ§¬ Real Data Integration
- **TCGA Integration Complete**: 254 authentic patient samples
- **Genomic Validation**: 99 verified genomic features
- **Clinical Data**: Real clinical variables and outcomes
- **Mutation Analysis**: 383 authentic cancer gene mutations

### ğŸ“„ Manuscript Updates
- **Main Paper**: Updated to 1.98MB with complete figures and citations
- **Architecture Paper**: Enhanced to 1.66MB with embedded diagrams
- **Professional Citations**: Proper inline citations and references
- **Data Availability**: Complete sections with repository links

## [2025-07-15] - Production Demo Release

### ğŸ Demo Package
- **Production Demo v2.0**: Self-contained 563KB package
- **LightGBM Model**: 1.5MB production model included
- **Automated Setup**: One-command installation with `python setup.py`
- **Cross-Platform**: Windows, Mac, Linux support with Docker

### ğŸ”§ Technical Improvements
- **SHAP Integration**: Full model interpretability
- **Pipeline Optimization**: Standard scaler and preprocessing
- **Verification Scripts**: Installation and system verification
- **Documentation**: Complete README and Quick Start guides

## [2025-06-30] - Architecture Innovation

### ğŸ¤– AI Architecture Advances
- **TabTransformer**: Attention-based tabular data processing
- **Multi-Modal Transformers**: Cross-modal attention mechanisms
- **Perceiver IO**: General-purpose multi-modal architecture
- **Ensemble Methods**: Stacking meta-learners and optimization

### ğŸ”¬ Feature Engineering
- **Biological Interactions**: Mutual information analysis
- **Multi-Omics Integration**: RNA, DNA methylation, clinical data
- **Genomic Features**: Mutations and copy number variations
- **Protein Expression**: Proteomic profile integration

## [2025-06-01] - Foundation Release

### ğŸ—ï¸ Initial Release
- **Project Foundation**: Core architecture and methodology
- **Patent Protection**: Provisional application filed
- **Academic License**: Open source license for research
- **Basic Models**: Initial machine learning implementations

### ğŸ“š Documentation
- **README**: Comprehensive project documentation
- **Contributing Guide**: Guidelines for collaboration
- **License Terms**: Academic and commercial use terms
- **Patent Information**: Legal protection documentation

---

## Future Roadmap

### ğŸ”„ In Progress
- **Clinical Validation Studies**: Preparation with verified real genomic data
- **Regulatory Pathway**: FDA 510k planning with explainable AI framework
- **Clinical Partnerships**: Development leveraging proven TCGA validation

### ğŸ“ Upcoming
- **Journal Submission**: Target journals for architecture and methodology papers
- **Clinical Deployment**: Hospital integration and commercial licensing
- **Expanded Validation**: Additional cancer types and larger datasets

---

*For the latest updates, see the main [README.md](README.md) file.*
